# Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

> **NCT00975663** · PHASE4 · TERMINATED · sponsor: **University Hospital, Limoges** · enrollment: 180 (estimated)

## Conditions studied

- Lung and Heart-lung Transplantation

## Interventions

- **DRUG:** Tacrolimus and MMF
- **DRUG:** Tacrolimus and MMF

## Key facts

- **NCT ID:** NCT00975663
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2011-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00975663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00975663, "Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00975663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*